The influence of nodal status on progression outcomes in patients with prostate cancer: Data from the Early Prostate Cancer program at 7.4 years.

被引：0
|
作者：
Iversen, P.
Wirth, M. P.
See, W. A., II
Mcleod, D. G.
Morris, T.
Armstrong, J.
机构：
[1] Rigshosp, DK-2100 Copenhagen, Denmark
[2] Tech Univ Dresden, D-8027 Dresden, Germany
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[4] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[5] AstraZeneca, Macclesfield, Cheshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：248S / 248S
页数：1
相关论文
共 50 条
  • [31] Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy
    Zhao, Zhigang
    Ma, Wenjing
    Zeng, Guohua
    Qi, Defeng
    Ou, Lili
    Liang, Yeping
    PROSTATE, 2012, 72 (03): : 270 - 279
  • [32] Survival outcomes in prostate cancer patients with a prior cancer
    Zang, Yan
    Qi, Feng
    Cheng, Yifei
    Xia, Tian
    Xiao, Rongrong
    Li, Xiao
    Yang, Ningli
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (02) : 741 - +
  • [33] Is insurance status associated with survival in prostate cancer patients? Data from CaPSURET.
    Sadetsky, N.
    Greene, K.
    DuChane, J.
    Carroll, P. R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S113 - S113
  • [34] Primary cilia are lost early in prostate cancer progression
    Hassounah, Nadia
    McDermott, Kimberly
    Nagle, Raymond
    CANCER RESEARCH, 2012, 72
  • [35] Innovative biomarkers for prostate cancer early diagnosis and progression
    You, Jingjing
    Cozzi, Paul
    Walsh, Bradley
    Willcox, Mark
    Kearsley, John
    Russell, Pamela
    Li, Yong
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 73 (01) : 10 - 22
  • [36] Influence of step sections on lymph node status in prostate cancer patients
    Birte, Engvad
    Mads, H. Poulsen
    Pia, W. Staun
    Steen, Walter
    Niels, Marcussen
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 : 37 - 37
  • [37] ERG-negative index tumor status combined with obesity predict prostate cancer progression in Caucasian American prostate cancer patients
    Cullen, Jennifer
    Young, Denise
    Chen, Yongmei
    Degon, Michael S.
    Baptiste, Wagner
    Farrell, James S.
    Sedarsky, Jason S.
    Kuo, Huai-Ching
    Kagan, Jacob
    Srivastava, Sudhir
    Rosner, Inger L.
    Petrovics, Gyorgy
    Dobi, Albert
    McLeod, David G.
    Srivastava, Shiv
    Sesterhenn, Isabel A.
    CANCER RESEARCH, 2016, 76
  • [38] Heterogeneity of Radiological Progression Patterns and Association with Outcomes in Patients with Metastatic Prostate Cancer
    Ni, Xudong
    Wu, Junlong
    Pan, Jian
    Li, Xiaomeng
    Fang, Bangwei
    Wei, Yu
    Ye, Dingwei
    Liang, Fei
    Zhu, Yao
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 897 - 905
  • [39] Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
    Lin, Ting-Ting
    Chen, Ye-Hui
    Wu, Yu-Peng
    Chen, Shao-Zhan
    Li, Xiao-Dong
    Lin, Yun-Zhi
    Chen, Shao-Hao
    Zheng, Qing-Shui
    Wei, Yong
    Xu, Ning
    Xue, Xue-Yi
    JOURNAL OF CANCER, 2019, 10 (22): : 5608 - 5613
  • [40] The influence of antidiabetic medications on the development and progression of prostate cancer
    Hitron, Anna
    Adams, Val
    Talbert, Jeff
    Steinke, Doug
    CANCER EPIDEMIOLOGY, 2012, 36 (04) : E243 - E250
12345